START study: enrolling well, open DSMB report shows no concerns
Most important strategy study looks on track...
View ArticleThe importance of evidence for “When to Start”: a response to Dr Myron Cohen
Tired of prominent researchers merging medical benefits from treatment with the use of treatment as prevention? The elephant in the room is the lack of evidence for such a dramatic change in public...
View ArticleSTART study open DSMB report (May 2014)
Updated 58-page report on baseline data and ongoing safety evaluations from the most important ongoing randomised study.
View ArticleHIV, gay men and drug use: ASTRA study and comment in The Lancet HIV
A research group I am involved with has just had a paper published in the new online publication The Lancet HIV. This paper is available free in full. [1] This is interesting for compiling results from...
View ArticleThe PROUD study: access to PrEP in the UK to prevent HIV
Links to two new articles on PrEP...
View ArticleMethmephangee – ChemSex vs recreational drug use
A definition of ChemSex, proposed by activists from 56 Dean Street and ReShape makes the essential distinction between ChemSex and recreational drugs for sex. ChemSex is NOT the same as recreational...
View ArticleSTART study reports 18 months early: impact will change guidelines globally
Links to three new articles and a short personal comment...
View ArticleActivists call for urgency of NHS access to PrEP
As a result of the PROUD study, the NHS now has plenty of evidence for effectiveness of PrEP...
View ArticleBite-size news from EACS… remarkable results with dolutegravir monotherapy
Simon Collins, HIV i-Base This European meeting will be significant for presenting numerous studies where treatment experienced patients have been maintained for months on dolutegravir monotherapy:...
View ArticleImpact of early ART on lung function: START substudy
This article has been moved from a blog post to an ahead-of-press HTB article and is online at this link: Impact of early ART on lung function: important results on ART and COPD from START substudy
View ArticleWhy dolutegravir might get us closer to ending AIDS: next step, further...
Unexpected and exciting results from five independent research groups that even experts are unsure of how to explain...
View ArticleOpen mic talk: HIV, HCV, new drugs and treatment access
This blog is a from a 5-minute open mic talk last night held downstairs at KuKlub bar in Soho. I hadn’t planned to speak until I got to the bar, but wanted to link four current stories about HIV, HCV, …
View ArticleAre patient information leaflets for research studies too difficult to read?...
This talk was for the British HIV Association spring conference. It was a small study lead by advocates at i-Base and was selected by the conference for an oral presentation (Abstract O_4). The study...
View Article
More Pages to Explore .....